Table 1

Multivariable stratified analyses for the risk of SLE associated with ITP or AIHA exposure in the propensity-score matched (1:2) populations

ITPAIHA
Non-ITPITPHR (95% CI)P valueP for interactionNon-AIHAAIHAHR (95% CI)P valueP for interaction
No. of events/total no. of patients
(per 105 person months)
No. of events/total no. of patients
(per 105 person months)
Overall5/6358 (1.36)307/3179 (197.44)135.91 (56.16 to 328.92)<0.0014/1828 (3.96)138/914 (357.31)83.96 (31.03 to 227.21)<0.001
Age (years)0.9660.376
 <655/4479 (1.82)280/2246 (239.92)124.33 (51.34 to 301.11)<0.0013/1100 (4.45)122/552 (472.11)103.83 (32.93 to 327.37)<0.001
 ≥650/1879 (0.00)27/933 (69.61)Cannot estimate0.9881/728 (2.96)16/362 (125.19)42.89 (5.41 to 339.81)<0.001
Gender0.9640.981
 Female5/4220 (1.97)265/2110 (253.08)118.62 (48.95 to 287.43)<0.0014/1130 (6.21)109/565 (457.11)68.09 (24.99 to 185.53)<0.001
 Male0/2138 (0.00)42/1069 (82.71)Cannot estimate0.9850/698 (0.00)29/349 (196.26)Cannot estimate0.992
  • AIHA, autoimmune haemolytic anaemia; ITP, immune thrombocytopenia; SLE, systemic lupus erythematosus.